Myosteatosis predicts short-term mortality in patients with COVID-19: A multicenter analysis
Description
CONCLUSIONS: Myosteatosis is strongly associated with 30-d mortality in patients COVID-19. Patients with COVID-19 with myosteatosis should be considered a risk group.
